サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1536126

頸部ジストニア治療の世界市場

Cervical Dystonia Treatment

出版日
ページ情報
英文 282 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
頸部ジストニア治療の世界市場
出版日: 2024年08月16日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 282 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

頸部ジストニア治療の世界市場は2030年までに6億9,350万米ドルに達する見込み

2023年に5億290万米ドルと推定された頸部ジストニア治療の世界市場は、2030年には6億9,350万米ドルに達し、分析期間2023-2030年のCAGRは4.7%で成長すると予測されます。ボツリヌス毒素注射は、本レポートで分析したセグメントの1つであり、CAGRは4.6%を記録し、分析期間終了時には2億8,440万米ドルに達すると予測されます。経口薬セグメントの成長率は、分析期間中CAGR 6.8％と推定されます。

米国市場は1億3,700万米ドルと推定、中国はCAGR 7.7％で成長すると予測

米国の頸部ジストニア治療市場は、2023年に1億3,700万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 7.7%で推移し、2030年には1億4,190万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8%と4.9%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の頸部ジストニア治療市場- 主要動向と促進要因まとめ

痙攣性斜頸としても知られる頸部ジストニアは、頸部の不随意な筋収縮を特徴とする神経疾患で、頭部の異常な動きや姿勢につながります。この疾患は重大な痛みや不快感を引き起こし、人の生活の質に影響を与えます。頸部ジストニアの治療の第一目標は、筋収縮の重症度を下げ、痛みを緩和し、機能的能力を改善することです。ボツリヌス毒素注射（ボトックス、ディスポート、ゼオミンなど）は、最も一般的に使用されている効果的な治療法です。これらの注射は、筋収縮を引き起こす神経信号を遮断することで効果を発揮し、数ヵ月にわたって緩和をもたらします。抗コリン薬、筋弛緩薬、ベンゾジアゼピン系薬剤などの内服薬も使用されるが、その効果はさまざまで、副作用を伴うことも多いです。より重症の場合は、脳の特定部位に電極を埋め込んで異常信号を調整する脳深部刺激療法（DBS）などの外科的介入も考慮されます。

頸部ジストニアの治療における最近の進歩により、患者の予後は大幅に改善しました。より洗練されたボツリヌス毒素製剤と注入技術の開発により、この治療の精度と有効性が向上しました。さらに、超音波と筋電図（EMG）ガイダンスの出現により、臨床医は罹患した筋肉をより正確に標的にすることができるようになり、より良い結果と副作用の軽減につながっています。ジストニアの根本的なメカニズムに関する調査により、遺伝子治療や神経保護剤などの新しい治療法への道も開かれました。理学療法や作業療法などのリハビリテーション療法は、頸部ジストニアの管理において重要な役割を果たします。これらの治療法は、ストレッチや筋力強化運動、姿勢矯正、疼痛管理戦略に重点を置き、全体的な機能性と生活の質を改善するための薬物療法を補完するものです。

頸部ジストニア治療市場の成長は、いくつかの要因によってもたらされます。この疾患に対する認識と診断の高まりが、効果的な治療に対する需要の高まりにつながっています。ボツリヌス毒素製剤や注入技術の改良など、医療技術の進歩が治療効果と患者の満足度を高めています。神経疾患の有病率の上昇や高齢化も市場拡大に寄与しています。さらに、現在進行中の研究開発により、遺伝子治療や新しい薬理学的薬剤など、新しく革新的な治療オプションが導入されています。遠隔医療とデジタルヘルスプラットフォームの統合は、より良い患者管理とフォローアップケアを促進し、普及を促進しています。さらに、ジストニア治療に対するヘルスケア政策や保険適用が支持され、これらの治療がより利用しやすくなっています。こうした動向が進化を続ける中、頸部ジストニア治療市場は、技術の進歩や患者中心の包括的ケアの重視の高まりによって、持続的な成長が見込まれています。

調査対象企業の例（全86件）

  • AbbVie, Inc.
  • AEON Biopharma
  • Eisai Co., Ltd.
  • Ipsen Pharma
  • Merz Therapeutics GmbH
  • Revance Therapeutics, Inc.
  • Supernus Pharmaceuticals, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26675

Global Cervical Dystonia Treatment Market to Reach US$693.5 Million by 2030

The global market for Cervical Dystonia Treatment estimated at US$502.9 Million in the year 2023, is expected to reach US$693.5 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Botulinum Toxin Injections, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$284.4 Million by the end of the analysis period. Growth in the Oral Medications segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$137.0 Million While China is Forecast to Grow at 7.7% CAGR

The Cervical Dystonia Treatment market in the U.S. is estimated at US$137.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$141.9 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Cervical Dystonia Treatment Market - Key Trends and Drivers Summarized

Cervical dystonia, also known as spasmodic torticollis, is a neurological disorder characterized by involuntary muscle contractions in the neck, leading to abnormal movements and postures of the head. This condition can cause significant pain and discomfort, affecting a person's quality of life. The primary goal of treatment for cervical dystonia is to reduce the severity of muscle contractions, alleviate pain, and improve functional abilities. Botulinum toxin injections (e.g., Botox, Dysport, Xeomin) are the most commonly used and effective treatment. These injections work by blocking the nerve signals that cause muscle contractions, providing relief for several months. Oral medications such as anticholinergics, muscle relaxants, and benzodiazepines are also used, though their effectiveness varies and they often come with side effects. In more severe cases, surgical interventions such as deep brain stimulation (DBS) may be considered, where electrodes are implanted in specific areas of the brain to regulate abnormal signals.

Recent advancements in the treatment of cervical dystonia have significantly improved patient outcomes. The development of more refined botulinum toxin formulations and injection techniques has enhanced the precision and effectiveness of this therapy. Additionally, the advent of ultrasound and electromyography (EMG) guidance has enabled clinicians to target affected muscles more accurately, leading to better results and reduced side effects. Research into the underlying mechanisms of dystonia has also paved the way for potential new treatments, including gene therapy and neuroprotective agents. Rehabilitation therapies, including physical therapy and occupational therapy, play a crucial role in managing cervical dystonia. These therapies focus on stretching and strengthening exercises, posture correction, and pain management strategies, complementing pharmacological treatments to improve overall functionality and quality of life.

The growth in the cervical dystonia treatment market is driven by several factors. Increasing awareness and diagnosis of the condition are leading to higher demand for effective treatments. Advances in medical technology, such as improved botulinum toxin formulations and injection techniques, are enhancing treatment efficacy and patient satisfaction. The rising prevalence of neurological disorders and an aging population are also contributing to market expansion. Moreover, ongoing research and development efforts are introducing new and innovative treatment options, including potential gene therapies and novel pharmacological agents. The integration of telemedicine and digital health platforms is facilitating better patient management and follow-up care, driving adoption. Additionally, supportive healthcare policies and insurance coverage for dystonia treatments are making these therapies more accessible. As these trends continue to evolve, the cervical dystonia treatment market is expected to experience sustained growth, driven by technological advancements and a growing emphasis on comprehensive, patient-centered care.

Select Competitors (Total 86 Featured) -

  • AbbVie, Inc.
  • AEON Biopharma
  • Eisai Co., Ltd.
  • Ipsen Pharma
  • Merz Therapeutics GmbH
  • Revance Therapeutics, Inc.
  • Supernus Pharmaceuticals, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cervical Dystonia Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Awareness and Diagnosis of Cervical Dystonia Expands Addressable Market Opportunity
    • Advances in Botulinum Toxin Formulations Propel Market Growth
    • Improved Injection Techniques Strengthen Business Case for Botulinum Toxin Treatments
    • Integration of Ultrasound and EMG Guidance Enhances Treatment Precision
    • Rising Prevalence of Neurological Disorders Drives Demand for Effective Therapies
    • Aging Population Generates Increased Need for Cervical Dystonia Treatments
    • Development of Gene Therapy Options Throws the Spotlight on Innovative Treatments
    • Enhanced Rehabilitation Therapies Accelerate Demand for Comprehensive Care Solutions
    • Research into Neuroprotective Agents Expands Treatment Horizons
    • Telemedicine and Digital Health Platforms Drive Adoption of Remote Patient Management
    • Increasing Patient Preference for Minimally Invasive Treatments Propels Growth
    • Improved Patient Outcomes with Advanced Therapeutics Strengthen Market Dynamics
    • Focus on Pain Management Solutions Generates Demand for Multi-modal Therapies
    • Development of Personalized Treatment Plans Drives Adoption of Targeted Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cervical Dystonia Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cervical Dystonia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Botulinum Toxin Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Botulinum Toxin Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Botulinum Toxin Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oral Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oral Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Oral Medications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics & Rehabilitation Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics & Rehabilitation Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Clinics & Rehabilitation Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Home Care End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Home Care End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cervical Dystonia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cervical Dystonia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cervical Dystonia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cervical Dystonia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cervical Dystonia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Cervical Dystonia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cervical Dystonia Treatment by Treatment Type - Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Cervical Dystonia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Botulinum Toxin Injections, Oral Medications, Deep Brain Stimulation and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cervical Dystonia Treatment by End-Use - Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Cervical Dystonia Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics & Rehabilitation Centers End-Use and Home Care End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION